| First and second serum TSP2 tertiles (N = 98) | Third serum TSP2 tertile (N = 48) | p-value |
---|---|---|---|
IVSd (mm) | Â | Â | Â |
Baseline | 10.62 ± 1.79 | 11.05 ± 2.22 | 0.22 |
Follow-up | 11.19 ± 1.82 | 11.91 ± 2.18 | 0.05 |
Change | 0.57 ± 1.28 | 0.86 ± 1.23 | 0.20 |
LVPWd (mm) | Â | Â | Â |
Baseline | 9.07 ± 1.10 | 9.65 ± 1.51 | < 0.05 |
Follow-up | 9.41 ± 1.40 | 9.85 ± 1.69 | 0.10 |
Change | 0.32 ± 1.43 | 0.19 ± 1.41 | 0.61 |
LVM (g) | Â | Â | Â |
Baseline | 145.19 ± 37.75 | 161.46 ± 48.82 | < 0.05 |
Follow-up | 153.60 ± 40.27 | 168.53 ± 48.76 | 0.05 |
Change | 8.41 ± 13.68 | 7.06 ± 14.07 | 0.58 |
LVEF (%) | Â | Â | Â |
Baseline | 66.13 ± 3.72 | 64.99 ± 4.40 | 0.12 |
Follow-up | 64.38 ± 4.45 | 62.62 ± 4.63 | < 0.05 |
Change | −1.75 ± 5.33 | −2.49 ± 5.32 | 0.45 |
E/A | Â | Â | Â |
Baseline | 0.91 ± 0.24 | 1.02 ± 0.63 | 0.13 |
Follow-up | 0.84 ± 0.19 | 0.91 ± 0.39 | 0.27 |
Change | −0.07 ± 0.21 | −0.04 ± 0.21 | 0.51 |
e’ septal (cm/s) |  |  |  |
Baseline | 7.62 ± 1.91 | 7.54 ± 2.17 | 0.83 |
Follow-up | 7.12 ± 1.76 | 6.63 ± 2.07 | 0.14 |
Change | −0.47 ± 2.00 | −0.92 ± 1.66 | 0.18 |
e’ lateral (cm/s) |  |  |  |
Baseline | 10.23 ± 2.34 | 10.13 ± 2.94 | 0.83 |
Follow-up | 9.51 ± 2.18 | 8.90 ± 2.54 | 0.13 |
Change | −0.77 ± 1.87 | −1.23 ± 1.78 | 0.16 |
Average E/e’ |  |  |  |
Baseline | 8.74 ± 2.36 | 9.53 ± 3.45 | 0.16 |
Follow-up | 9.36 ± 2.70 | 11.00 ± 3.75 | < 0.01 |
Change | 0.57 ± 2.09 | 1.48 ± 2.35 | < 0.05 |
LAVi (ml/m2) | Â | Â | Â |
Baseline | 30.22 ± 8.23 | 32.42 ± 10.28 | 0.19 |
Follow-up | 28.82 ± 7.98 | 33.78 ± 10.80 | < 0.01 |
Change | −1.32 ± 7.35 | 2.09 ± 8.90 | < 0.05 |